MDLZ BLUECHIP_DIP Open
Food Products · UNDERPERFORM
Bluechip 1.00% confidence · Bull Market · BLUECHIP_DIP
4/7 Quality
Entry
$60.91
Stop Loss
$51.77
TP1
$76.14
TP2
$83.75
R:R
1.67

Analyst vs AI Verdict

ALIGNED

Wall Street

64.7% Buy Rating
8
Strong Buy
14
Buy
12
Hold
0
Sell
0
Strong Sell
34 analysts · June 1, 2026

AI Expert Panel

STRONG_BUY
Gemini BUY
ChatGPT BUY
Grok SKIP
Claude BUY

Price Chart

Entry Reason

Drawdown 14% (within range) | Price < SMA50 (short-term dip) | RSI oversold (50) | RSI turning up (43 → 50)

Entry Technical Conditions

Methodology →
RSI
50.2
Neutral
ADX
22.1
Moderate
Volume
0.95x
Normal
BB Pos
0.44
Mid
ATR %
2.5%
Normal

AI Expert Panel

STRONG_BUY
Gemini BUY ⏳ Pending

Mondelez is currently showing signs of stabilization after a period of volatility, with the stock finding support around the $60 level. The recent analyst endorsement regarding easing cocoa pressures provides a strong fundamental catalyst for margin expansion in the coming weeks. While the company faces risks related to its high debt-to-equity ratio and a tight current ratio, its steady revenue growth and defensive nature make it an attractive swing candidate in a fluctuating market. I anticipate a move toward the $64-$65 resistance level within the 2-12 week horizon, offering a solid risk-to-reward profile for a short-term trade.

ChatGPT BUY ⏳ Pending

Price action: Mondelez has been trading in a tight 60–62 range recently, with current price around 60.9 and no clear breakout yet; a move above roughly 62–62.5 on strong volume could confirm the start of an upside swing, while a quick break below ~59 could trigger a dip. Fundamentals: MDLZ shows solid defensive fundamentals for a swing setup (beta 0.39, ROE 13.4%, net margin 9.4%, P/E 19.7, dividend yield 3.72%); revenue growth is healthy (3Y 8.3%, 5Y 7.1%), and positive sentiment from recent coverage (Morgan Stanley top pick, cocoa pressures easing) supports upside potential despite a low current ratio 0.61 indicating liquidity risk. Risks: key risks over 2–12 weeks include macro market weakness, commodity input volatility (cocoa, sugar), currency effects, and possible sector rotation; near-term liquidity risk is notable given the current ratio, which could constrain operations if cash needs spike. Final verdict and upside: a tactical BUY is reasonable given the setup and catalysts, with an estimated 4–7% upside if a breakout occurs ( Targets around 63–64+), while maintaining a tight stop near 59–60 to manage downside risk.

Grok SKIP ⏳ Pending

Price action shows MDLZ recovering from a sharp decline off 2025 highs near 71 down to the low 50s, with the current 60.91 level sitting in a choppy consolidation range between 57-62 over the past two months and lacking clear breakout momentum or volume surge for a swing entry. Fundamentals reflect a stable defensive food company with solid ROE, reasonable P/E, and attractive dividend yield, but weak liquidity (current ratio 0.61) and elevated leverage limit aggressive near-term upside. Key risks over 2-12 weeks include ongoing cocoa cost volatility, potential consumer pullback in snacks, and broader market swings that could push the low-beta stock sideways rather than higher. Overall verdict is SKIP as there is no compelling entry catalyst for a quick 2-12 week trade, with estimated upside capped at 3-6% before resistance at 63-65.

Claude BUY ⏳ Pending

MDLZ presents a compelling swing trade entry point at $60.91, which sits near the lower end of its recent trading range (52-week low ~$51.20, recent resistance ~$64) and represents a 12% discount from July 2025 highs, suggesting oversold conditions ripe for mean reversion. The company's fundamental health is solid with a 19.7 P/E (reasonable for consumer staples), 8.3% 3-year revenue growth, 3.72% dividend yield, and recent analyst upgrade from Morgan Stanley citing easing cocoa pressures—a key input cost headwind that has likely depressed the stock. Price action shows a clear bottoming pattern from January-April 2026 lows (~$54-57), followed by consolidation and recent recovery attempts, with technical support building around $60-61; the stock has demonstrated 3-5% bounce potential multiple times in recent months, suggesting $63-65 is an achievable 2-12 week target (4-7% upside). Key risks include the elevated D/E ratio of 81.45 and weak current ratio of 0.61 indicating leverage and liquidity concerns, plus the low beta (0.39) means MDLZ won't participate aggressively in broad market rallies, but the Morgan Stanley upgrade and cocoa tailwinds provide near-term catalysts for a tactical 5-7% swing trade profit within the 2-12 week window.

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) 13.6% 13.6% 13.6% 13.4% 13.4% 13.4%
P/E (TTM) 23.98 22.54 22.23 21.00 20.46 19.67
Net Margin 7.1% 9.8% 9.8% 9.4% 9.4% 9.4%
Gross Margin 32.7% 32.5% 32.5% 31.1% 31.1% 31.1%
D/E Ratio 79.74 79.74 79.74 81.45 81.45 81.45
Current Ratio 0.64 0.64 0.64 0.61 0.61 0.61

Context Synthesis

2/3 Bullish
Analysts
64.7% Buy
Insiders
Bearish
Institutions
29.71%
Earnings Beat
100.0%
Full analysis →

Quality Checks

Entry confidence: 0.50 → base 2/5
Portrait: bluechip_buy → bonus +2

Signal Info

Created Jul 03, 2026 14:02
Updated Jul 03, 2026 14:02
Market Bull
Strategy BLUECHIP_DIP
Timeout 90 days

Disclaimer: This is an automated trading signal generated by AI analysis. It is not financial advice. Always do your own research before making investment decisions. Past performance does not guarantee future results.